| 0 |
POSTOPERATIVE ANALGESIA |
1 |
0.2000 |
| 1 |
BLOOD PRESSURE AMBULATORY DECREASED |
1 |
0.0667 |
| 2 |
ANAESTHESIA ORAL |
3 |
0.0448 |
| 3 |
VTH NERVE INJURY |
1 |
0.0204 |
| 4 |
COMPULSIVE CHEEK BITING |
1 |
0.0196 |
| 5 |
THERAPEUTIC PRODUCT EFFECT PROLONGED |
8 |
0.0177 |
| 6 |
TONGUE NECROSIS |
1 |
0.0137 |
| 7 |
DRUG EFFECT PROLONGED |
7 |
0.0127 |
| 8 |
PARAESTHESIA MUCOSAL |
1 |
0.0108 |
| 9 |
INTRANASAL HYPOAESTHESIA |
1 |
0.0106 |
| 10 |
PRODUCT PRIMARY PACKAGING ISSUE |
1 |
0.0089 |
| 11 |
POST PROCEDURAL SWELLING |
9 |
0.0082 |
| 12 |
GINGIVAL ULCERATION |
4 |
0.0053 |
| 13 |
INJECTION SITE ULCER |
5 |
0.0053 |
| 14 |
TISSUE INJURY |
2 |
0.0046 |
| 15 |
GINGIVAL DISCOLOURATION |
2 |
0.0037 |
| 16 |
HYPOAESTHESIA EYE |
2 |
0.0034 |
| 17 |
INJECTION SITE PALLOR |
1 |
0.0032 |
| 18 |
CORNEAL REFLEX DECREASED |
1 |
0.0027 |
| 19 |
ORAL MUCOSAL EXFOLIATION |
4 |
0.0026 |
| 20 |
INCISION SITE IMPAIRED HEALING |
1 |
0.0025 |
| 21 |
PROCEDURAL HEADACHE |
1 |
0.0024 |
| 22 |
SYSTOLIC HYPERTENSION |
1 |
0.0023 |
| 23 |
DELAYED RECOVERY FROM ANAESTHESIA |
2 |
0.0021 |
| 24 |
HYPOAESTHESIA ORAL |
29 |
0.0019 |
| 25 |
SOFT TISSUE SWELLING |
1 |
0.0018 |
| 26 |
TRISMUS |
9 |
0.0017 |
| 27 |
ADMINISTRATION SITE PAIN |
2 |
0.0017 |
| 28 |
METAL POISONING |
1 |
0.0017 |
| 29 |
GINGIVAL RECESSION |
3 |
0.0016 |
| 30 |
INJECTION SITE NECROSIS |
3 |
0.0015 |
| 31 |
SOFT TISSUE NECROSIS |
1 |
0.0015 |
| 32 |
INJECTION SITE INFLAMMATION |
7 |
0.0014 |
| 33 |
BRAIN STEM SYNDROME |
1 |
0.0013 |
| 34 |
INADEQUATE ANALGESIA |
11 |
0.0013 |
| 35 |
PROCEDURAL NAUSEA |
1 |
0.0012 |
| 36 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 37 |
MOUTH SWELLING |
7 |
0.0012 |
| 38 |
SUSPECTED PRODUCT QUALITY ISSUE |
2 |
0.0011 |
| 39 |
PHARYNGEAL HYPOAESTHESIA |
1 |
0.0011 |
| 40 |
LOCAL ANAESTHETIC SYSTEMIC TOXICITY |
1 |
0.0009 |
| 41 |
FACIAL SPASM |
1 |
0.0009 |
| 42 |
PALATAL OEDEMA |
1 |
0.0008 |
| 43 |
IATROGENIC INJURY |
1 |
0.0008 |
| 44 |
TONIC CLONIC MOVEMENTS |
1 |
0.0008 |
| 45 |
PHARYNGEAL ULCERATION |
1 |
0.0008 |
| 46 |
ANAESTHETIC COMPLICATION |
2 |
0.0007 |
| 47 |
EXCESSIVE EYE BLINKING |
1 |
0.0007 |
| 48 |
BLOOD PRESSURE IMMEASURABLE |
1 |
0.0007 |
| 49 |
NEURITIS |
1 |
0.0006 |
| 50 |
PARAESTHESIA ORAL |
9 |
0.0006 |
| 51 |
INJECTION SITE INFECTION |
2 |
0.0006 |
| 52 |
ORAL DISORDER |
4 |
0.0005 |
| 53 |
TUNNEL VISION |
1 |
0.0005 |
| 54 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 55 |
GINGIVAL SWELLING |
2 |
0.0005 |
| 56 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
2 |
0.0004 |
| 57 |
ISCHAEMIA |
2 |
0.0004 |
| 58 |
BILIRUBIN CONJUGATED INCREASED |
1 |
0.0004 |
| 59 |
BLINDNESS TRANSIENT |
3 |
0.0004 |
| 60 |
EYELID IRRITATION |
1 |
0.0004 |
| 61 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 62 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 63 |
GINGIVAL PAIN |
3 |
0.0004 |
| 64 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 65 |
LARYNGOSPASM |
1 |
0.0004 |
| 66 |
LIP BLISTER |
1 |
0.0004 |
| 67 |
NERVE INJURY |
4 |
0.0004 |
| 68 |
ELECTRIC SHOCK SENSATION |
1 |
0.0004 |
| 69 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 70 |
FACIAL PARALYSIS |
3 |
0.0004 |
| 71 |
FACIAL PAIN |
3 |
0.0003 |
| 72 |
MOUTH ULCERATION |
7 |
0.0003 |
| 73 |
DYSAESTHESIA |
1 |
0.0003 |
| 74 |
LARYNGEAL OEDEMA |
2 |
0.0003 |
| 75 |
EYELIDS PRURITUS |
1 |
0.0003 |
| 76 |
ELECTROENCEPHALOGRAM ABNORMAL |
1 |
0.0003 |
| 77 |
OEDEMA MOUTH |
1 |
0.0003 |
| 78 |
PRODUCT FORMULATION ISSUE |
2 |
0.0003 |
| 79 |
DISCOMFORT |
18 |
0.0003 |
| 80 |
VIITH NERVE PARALYSIS |
1 |
0.0003 |
| 81 |
PAPULE |
2 |
0.0003 |
| 82 |
ANAPHYLACTIC SHOCK |
7 |
0.0003 |
| 83 |
GENERAL SYMPTOM |
2 |
0.0003 |
| 84 |
GINGIVAL DISORDER |
1 |
0.0003 |
| 85 |
MATERNAL EXPOSURE DURING BREAST FEEDING |
1 |
0.0002 |
| 86 |
ASPHYXIA |
2 |
0.0002 |
| 87 |
LIP SWELLING |
8 |
0.0002 |
| 88 |
DRUG INEFFECTIVE |
308 |
0.0002 |
| 89 |
ABNORMAL SENSATION IN EYE |
1 |
0.0002 |
| 90 |
SWELLING FACE |
15 |
0.0002 |
| 91 |
PALLOR |
6 |
0.0002 |
| 92 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 93 |
ORAL DISCOMFORT |
3 |
0.0002 |
| 94 |
HYPOAESTHESIA |
32 |
0.0002 |
| 95 |
AGEUSIA |
5 |
0.0002 |
| 96 |
INJECTION SITE DISCOMFORT |
2 |
0.0002 |
| 97 |
CHEILITIS |
1 |
0.0002 |
| 98 |
ERYTHEMA OF EYELID |
1 |
0.0002 |
| 99 |
HYPERTENSIVE CRISIS |
2 |
0.0002 |
| 100 |
NEUROTOXICITY |
3 |
0.0002 |
| 101 |
ODYNOPHAGIA |
1 |
0.0002 |
| 102 |
GANGRENE |
1 |
0.0002 |
| 103 |
INJECTION SITE DISCOLOURATION |
2 |
0.0002 |
| 104 |
BLEPHAROSPASM |
1 |
0.0002 |
| 105 |
INCOHERENT |
1 |
0.0002 |
| 106 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 107 |
INJURY ASSOCIATED WITH DEVICE |
3 |
0.0001 |
| 108 |
PARAESTHESIA |
23 |
0.0001 |
| 109 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 110 |
PROCEDURAL PAIN |
4 |
0.0001 |
| 111 |
BURNING SENSATION |
10 |
0.0001 |
| 112 |
BLINDNESS UNILATERAL |
2 |
0.0001 |
| 113 |
DRUG EFFECT INCOMPLETE |
5 |
0.0001 |
| 114 |
CEREBRAL DISORDER |
1 |
0.0001 |
| 115 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 116 |
ATRIOVENTRICULAR BLOCK |
1 |
0.0001 |
| 117 |
NASAL DISCOMFORT |
1 |
0.0001 |
| 118 |
RHINITIS |
1 |
0.0001 |
| 119 |
HYPERAESTHESIA |
1 |
0.0001 |
| 120 |
PRODUCT CONTAINER ISSUE |
1 |
0.0001 |
| 121 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 122 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 123 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 124 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 125 |
EMPHYSEMA |
1 |
0.0001 |
| 126 |
DRY THROAT |
1 |
0.0001 |
| 127 |
TOOTH ABSCESS |
1 |
0.0001 |
| 128 |
RENAL PAIN |
1 |
0.0001 |
| 129 |
IMPAIRED HEALING |
3 |
0.0001 |
| 130 |
ANGIOEDEMA |
4 |
0.0001 |
| 131 |
OBSTRUCTIVE AIRWAYS DISORDER |
1 |
0.0001 |
| 132 |
GLOSSODYNIA |
2 |
0.0001 |
| 133 |
SCAB |
1 |
0.0001 |
| 134 |
EYELID OEDEMA |
1 |
0.0001 |
| 135 |
MYOCLONUS |
1 |
0.0001 |
| 136 |
SECRETION DISCHARGE |
1 |
0.0001 |
| 137 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 138 |
THROAT TIGHTNESS |
2 |
0.0001 |
| 139 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 140 |
APHONIA |
1 |
0.0001 |
| 141 |
BRONCHOSPASM |
1 |
0.0001 |
| 142 |
BONE LOSS |
1 |
0.0001 |
| 143 |
INJECTION SITE SWELLING |
5 |
0.0001 |
| 144 |
INJECTION SITE PAIN |
20 |
0.0001 |
| 145 |
PHARYNGEAL OEDEMA |
1 |
0.0001 |
| 146 |
SWELLING |
6 |
0.0001 |
| 147 |
ARRHYTHMIA |
3 |
0.0001 |
| 148 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 149 |
EXPIRED PRODUCT ADMINISTERED |
2 |
0.0001 |
| 150 |
INFLAMMATION |
3 |
0.0001 |
| 151 |
LOCAL SWELLING |
1 |
0.0001 |
| 152 |
PRODUCT STORAGE ERROR |
5 |
0.0001 |
| 153 |
COLD SWEAT |
1 |
0.0001 |
| 154 |
TOOTHACHE |
1 |
0.0001 |
| 155 |
PANIC ATTACK |
2 |
0.0001 |
| 156 |
EYE SWELLING |
2 |
0.0001 |
| 157 |
DYSPHAGIA |
5 |
0.0001 |
| 158 |
FEELING JITTERY |
1 |
0.0001 |
| 159 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 160 |
CONTUSION |
5 |
0.0001 |
| 161 |
DYSTONIA |
1 |
0.0001 |
| 162 |
EAR PAIN |
1 |
0.0001 |
| 163 |
HEART RATE INCREASED |
5 |
0.0001 |
| 164 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 165 |
TASTE DISORDER |
1 |
0.0000 |
| 166 |
HALLUCINATION, VISUAL |
1 |
0.0000 |
| 167 |
SNEEZING |
1 |
0.0000 |
| 168 |
TINNITUS |
2 |
0.0000 |
| 169 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 170 |
MUSCLE TWITCHING |
1 |
0.0000 |
| 171 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
3 |
0.0000 |
| 172 |
PRESYNCOPE |
1 |
0.0000 |
| 173 |
INJECTION SITE URTICARIA |
1 |
0.0000 |
| 174 |
DIZZINESS |
20 |
0.0000 |
| 175 |
BLOOD PRESSURE INCREASED |
6 |
0.0000 |
| 176 |
RASH GENERALISED |
1 |
0.0000 |
| 177 |
DIPLOPIA |
1 |
0.0000 |
| 178 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 179 |
FEAR |
1 |
0.0000 |
| 180 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 181 |
TREMOR |
6 |
0.0000 |
| 182 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 183 |
URTICARIA |
6 |
0.0000 |
| 184 |
PAIN IN JAW |
1 |
0.0000 |
| 185 |
LETHARGY |
2 |
0.0000 |
| 186 |
SEIZURE |
4 |
0.0000 |
| 187 |
NEEDLE ISSUE |
1 |
0.0000 |
| 188 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 189 |
DYSPHONIA |
2 |
0.0000 |
| 190 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 191 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 192 |
EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 193 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 194 |
LOSS OF CONSCIOUSNESS |
4 |
0.0000 |
| 195 |
EYE DISORDER |
1 |
0.0000 |
| 196 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 197 |
VISUAL ACUITY REDUCED |
1 |
0.0000 |
| 198 |
SYNCOPE |
3 |
0.0000 |
| 199 |
GAIT INABILITY |
1 |
0.0000 |
| 200 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 201 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 202 |
PAIN |
18 |
0.0000 |
| 203 |
VISION BLURRED |
4 |
0.0000 |
| 204 |
RASH MACULAR |
1 |
0.0000 |
| 205 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 206 |
RESTLESSNESS |
1 |
0.0000 |
| 207 |
DYSGEUSIA |
2 |
0.0000 |
| 208 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 209 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 210 |
ABORTION SPONTANEOUS |
1 |
0.0000 |
| 211 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 212 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 213 |
MALAISE |
10 |
0.0000 |
| 214 |
LIVER DISORDER |
1 |
0.0000 |
| 215 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 216 |
NO ADVERSE EVENT |
4 |
0.0000 |
| 217 |
SKIN IRRITATION |
1 |
0.0000 |
| 218 |
OROPHARYNGEAL PAIN |
2 |
0.0000 |
| 219 |
RENAL DISORDER |
1 |
0.0000 |
| 220 |
CELLULITIS |
1 |
0.0000 |
| 221 |
FLUSHING |
2 |
0.0000 |
| 222 |
ERYTHEMA |
4 |
0.0000 |
| 223 |
NERVOUSNESS |
1 |
0.0000 |
| 224 |
SPEECH DISORDER |
1 |
0.0000 |
| 225 |
DEPRESSED MOOD |
1 |
0.0000 |
| 226 |
HYPERTENSION |
4 |
0.0000 |
| 227 |
ASPARTATE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 228 |
MEDICATION ERROR |
1 |
0.0000 |
| 229 |
BLISTER |
1 |
0.0000 |
| 230 |
HYPONATRAEMIA |
1 |
0.0000 |
| 231 |
ANXIETY |
5 |
0.0000 |
| 232 |
HERPES ZOSTER |
1 |
0.0000 |
| 233 |
PALPITATIONS |
2 |
0.0000 |
| 234 |
NASAL CONGESTION |
1 |
0.0000 |
| 235 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 236 |
RHINORRHOEA |
1 |
0.0000 |
| 237 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 238 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 239 |
INJURY |
1 |
0.0000 |
| 240 |
DYSPNOEA |
8 |
0.0000 |
| 241 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 242 |
MOBILITY DECREASED |
1 |
0.0000 |
| 243 |
RASH |
6 |
0.0000 |
| 244 |
HALLUCINATION |
1 |
0.0000 |
| 245 |
HOT FLUSH |
1 |
0.0000 |
| 246 |
FEELING ABNORMAL |
3 |
0.0000 |
| 247 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 248 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 249 |
BALANCE DISORDER |
1 |
0.0000 |
| 250 |
ADVERSE DRUG REACTION |
1 |
0.0000 |
| 251 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 252 |
ADVERSE EVENT |
1 |
0.0000 |
| 253 |
MIGRAINE |
1 |
0.0000 |
| 254 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 255 |
SOMNOLENCE |
2 |
0.0000 |
| 256 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 257 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 258 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 259 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 260 |
VOMITING |
4 |
0.0000 |
| 261 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 262 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 263 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 264 |
ASTHENIA |
3 |
0.0000 |
| 265 |
HEADACHE |
5 |
0.0000 |
| 266 |
HYPERHIDROSIS |
1 |
0.0000 |
| 267 |
DEHYDRATION |
1 |
0.0000 |
| 268 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 269 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 270 |
DRUG INTERACTION |
1 |
0.0000 |
| 271 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 272 |
MYALGIA |
1 |
0.0000 |
| 273 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 274 |
MUSCLE SPASMS |
1 |
0.0000 |
| 275 |
CHEST PAIN |
1 |
0.0000 |
| 276 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 277 |
PRURITUS |
2 |
0.0000 |
| 278 |
FATIGUE |
4 |
0.0000 |
| 279 |
NAUSEA |
4 |
0.0000 |
| 280 |
INSOMNIA |
1 |
0.0000 |
| 281 |
WEIGHT DECREASED |
1 |
0.0000 |
| 282 |
COUGH |
1 |
0.0000 |
| 283 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 284 |
FALL |
1 |
0.0000 |
| 285 |
OFF LABEL USE |
1 |
0.0000 |